Stabilizing protein drugs with a new reversible 'mixing-type' material
Protein drugs are widely used as pharmaceutical agents to treat a range of disorders. However, most of these drugs are not very stable and are only retained in the blood...
10 minutes ago - Phys
New research on tau's role in neurodegenerative diseases like Alzheimer's could inform new treatments
New research on tau's role in neurodegenerative diseases like Alzheimer's could inform new treatments klahucik Fri, 01/21/2022 - 13:51
46 minutes ago - Fierce Biotech
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock ntaylor Tue, 01/25/2022 - 06:23
46 minutes ago - Fierce Biotech
Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug
Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug ntaylor Tue, 01/25/2022 - 08:10
46 minutes ago - Fierce Biotech
Pfizer, BioNTech launch trial for potential omicron-busting vaccine
Pfizer, BioNTech launch trial for potential omicron-busting vaccine aarmstrong Tue, 01/25/2022 - 09:29
46 minutes ago - Fierce Biotech
Section 32 Expands Investment Team with the Addition of Carlos Solórzano, Ph.D
SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ - Section 32, a venture capital fund investing at the frontiers of technology and healthcare, announced today the addition of...
58 minutes ago - San Diego Biotechnology
Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry
SAN DIEGO-- advancedtherapies-Launching Excellos, an innovative cell and gene therapy CDMO, pairing collection of human cells/tissues with manufacturing and development services
58 minutes ago - San Diego Biotechnology
Tony O'Neill Joins Ajinomoto Bio-Pharma Services' Leadership Team as Vice President of Compliance
SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ - Ajinomoto Bio-Pharma Services , a leading global provider of bio-pharmaceutical contract development and manufacturing...
1 hour ago - San Diego Biotechnology
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster Clinical Trial
SAN DIEGO--- $ARCT ClinicalTrial-Arcturus Reports Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster...
1 hour ago - San Diego Biotechnology
Biomimetic manganese-eumelanin nanocomposites for combined hyperthermia-immunotherapy against prostate cancer
Pro-tumoral and immunosuppressive M2-like tumor-associated macrophages contribute to tumor progression, recurrence and distal metastasis. However, current TAMs-modulating...
2 hours ago - Journal of Nanobiotechnology
Free Registration
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Pfizer, BioNTech launch trial for potential omicron-busting vaccine
Pfizer, BioNTech launch trial for potential omicron-busting vaccine aarmstrong Tue, 01/25/2022 - 09:29
Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to...
Sierra's bet on Gilead castoff pays off, teeing up FDA filing for rival to Incyte-Novartis cancer drug ntaylor Tue, 01/25/2022 - 08:10
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock
AstraZeneca success torpedoes PCI's pivotal plan, crushing stock ntaylor Tue, 01/25/2022 - 06:23
New research on tau's role in neurodegenerative diseases like Alzheimer's...
New research on tau's role in neurodegenerative diseases like Alzheimer's could inform new treatments klahucik Fri, 01/21/2022 - 13:51
Section 32 Expands Investment Team with the Addition of Carlos Solórzano, Ph.D
SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ - Section 32, a venture capital fund investing at the frontiers of technology and healthcare, announced today the addition of...
Excellos Launches to Accelerate Innovation in the Cell and Gene Therapy Industry
SAN DIEGO-- advancedtherapies-Launching Excellos, an innovative cell and gene therapy CDMO, pairing collection of human cells/tissues with manufacturing and development services
Arcturus Therapeutics Reports New Data Demonstrating Neutralizing Antibody...
SAN DIEGO--- $ARCT ClinicalTrial-Arcturus Reports Data Demonstrating Neutralizing Antibody Immune Response to the SARS-CoV-2 Omicron Variant from ARCT-154 and ARCT-165 Booster...
Tony O'Neill Joins Ajinomoto Bio-Pharma Services' Leadership Team as Vice...
SAN DIEGO: SAN DIEGO, Jan. 25, 2022 /PRNewswire/ - Ajinomoto Bio-Pharma Services , a leading global provider of bio-pharmaceutical contract development and manufacturing...
Biomimetic manganese-eumelanin nanocomposites for combined...
Pro-tumoral and immunosuppressive M2-like tumor-associated macrophages contribute to tumor progression, recurrence and distal metastasis. However, current TAMs-modulating...
Exosome-liposome hybrid nanoparticle codelivery of TP and miR497...
Although cisplatin-based chemotherapy has been used as the first-line treatment for ovarian cancer , tumor cells develop resistance to cisplatin during treatment, causing poor...